Impairment of T and B cell development by treatment with a type I interferon.
about
Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interactionThe effects of TLR activation on T-cell development and differentiationRegulation of the type I IFN induction: a current viewAltered thymic function during interferon therapy in HCV-infected patientsCytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated miceIFN-alpha-induced upregulation of CCR5 leads to expanded HIV tropism in vivoIFN-α is constitutively expressed in the human thymus, but not in peripheral lymphoid organs.Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomesSignaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cellsInterferons mediate terminal differentiation of human cortical thymic epithelial cells.Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm.The interplay of dendritic cell subsets in systemic lupus erythematosus.IFN-α produced by human plasmacytoid dendritic cells enhances T cell-dependent naïve B cell differentiationPlasmacytoid dendritic cells and the control of herpesvirus infections.Immature B cells preferentially switch to IgE with increased direct Sμ to Sε recombination.Major differences in the responses of primary human leukocyte subsets to IFN-beta.Src homology 2-containing 5-inositol phosphatase (SHIP) suppresses an early stage of lymphoid cell development through elevated interleukin-6 production by myeloid cells in bone marrowInhibition of lupus by genetic alteration of the interferon-alpha/beta receptor.Virus-activated interferon regulatory factor 7 upregulates expression of the interferon-regulated BST2 gene independently of interferon signalingInflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression.Stimulated plasmacytoid dendritic cells impair human T-cell developmentChronic spinal cord injury impairs primary antibody responses but spares existing humoral immunity in miceImmunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production.Neonatally induced inactivation of the vascular cell adhesion molecule 1 gene impairs B cell localization and T cell-dependent humoral immune responseType-I interferon receptor deficiency reduces lupus-like disease in NZB mice.Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects.PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesisType I interferons in viral control and immune regulationAutoimmune diseases caused by defects in clearing dead cells and nuclei expelled from erythroid precursors.Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in miceVillous B cells of the small intestine are specialized for invariant NK T cell dependenceSystemic IFN-alpha drives kidney nephritis in B6.Sle123 miceResident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cells.Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.A perspective on B-cell-targeting therapy for SLE.A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodomain proteolysis and induce fatal inflammation.Daxx enhances Fas-mediated apoptosis in a murine pro-B cell line, BAF3.T-cell homeostasis in chronic HCV-infected patients treated with interferon and ribavirin or an interferon-free regimen.HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.
P2860
Q24309134-89CF9E09-88A9-470E-B774-AA164E6996A8Q27001581-FF0C2509-E109-49BA-BC90-BFCA834C9F0BQ28276339-B08C53AF-D262-4CD4-B223-6A6F1F2A61EDQ28730551-21863A37-E5CB-4851-AF54-22DAA43B4A09Q33374623-74EA08A6-F8FB-4212-9B83-114E75F0051AQ33533290-FD739330-BEA1-48C2-8439-96306B23EFA9Q34014536-B033370E-F602-474B-BA14-638B1D1EBC99Q34048667-EDB0734E-0992-41F2-9328-EF84D667F0CBQ34055580-26B76E50-E43B-4CB9-96EF-854E44BA467DQ34341479-1C1D89A0-32DD-4CCA-A54C-BE7229D023F0Q34608946-0FA71ED9-8637-417E-9F8F-D72534076CC5Q34842390-DEC6219F-649D-4320-8E1E-8E970C9195D8Q35001944-0D26BEBC-455E-4626-BAAE-2DDC4C0CD571Q35259804-0B00FC79-417B-4887-B318-04EC04C5ED8AQ35627706-80FF17A6-873D-4055-A4DF-D28B93473B3CQ35630626-5A4D2766-9898-4459-9DF2-CE1774BE7A7EQ35634878-9F6C0B43-AE33-4BD0-BCD4-FD9599C4484FQ35675526-44D55ECD-45C7-402A-A66C-6A37220D1C15Q35826825-35004D76-6C94-420D-A0AF-6798092AC44AQ35834713-3946C047-F262-47B6-850F-BA6E42BAC186Q35848849-92F1820D-7887-445D-8861-C6B76AF97B29Q35981021-81323BF9-E91F-45F1-9D1F-79025DC91AEEQ36368599-95D4BB4C-E39A-49E5-B73E-AA866F4E1C9FQ36369285-4AA2AFA0-7FAA-47A9-9C57-0018B84778D5Q36370602-62C8D469-A166-4830-9D4A-71B8D0474A30Q36401305-FC9430B4-EE32-4F21-8B30-13C2491D56A5Q36403595-1B1175EE-33EF-4B01-B70E-E067690E3859Q36767643-1069268D-3F2D-4D1C-9959-A7BA4478E427Q36990642-09D8E429-1068-4D03-9F4F-9327D01CA215Q37019912-E9649B61-9566-4520-A257-666F35A0BB1FQ37196466-CF100AA1-C3AB-42DD-A779-17E26A63C82EQ37234883-9A114ACE-B027-475C-8992-18A663C4EA1BQ37325186-59FF0885-FDBC-4A92-8879-BE8A618048FCQ37535318-1BAA2BC2-4241-4825-893B-E8066BBA593DQ37577571-F8B2E6FD-BC98-4C8E-AD19-5F8F5B31F847Q38537618-D764A443-9466-415B-BA19-1D89F1A2E049Q39589343-3FC5A9D3-3717-42B9-A143-28CFC3719525Q40656671-3D1143F9-B087-4598-A729-7D84E0649998Q41049230-D166BD1F-9EA9-4715-A066-A68DEBBDB568Q41952863-D1495C32-51A6-4895-BB33-245E99C65448
P2860
Impairment of T and B cell development by treatment with a type I interferon.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Impairment of T and B cell development by treatment with a type I interferon.
@ast
Impairment of T and B cell development by treatment with a type I interferon.
@en
type
label
Impairment of T and B cell development by treatment with a type I interferon.
@ast
Impairment of T and B cell development by treatment with a type I interferon.
@en
prefLabel
Impairment of T and B cell development by treatment with a type I interferon.
@ast
Impairment of T and B cell development by treatment with a type I interferon.
@en
P2093
P2860
P356
P1476
Impairment of T and B cell development by treatment with a type I interferon.
@en
P2093
P2860
P356
10.1084/JEM.187.1.79
P407
P577
1998-01-01T00:00:00Z